5-Minute Check In: New Developments in Allergy Treatments

from 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn · host CommonSpirit Health Physician Enterprise

Guest: Dr. Rajan K. Merchant, Allergy, Asthma, and Clinical Immunology Specialist, Dignity Health Woodland ClinicNeffy is the first FDA approved nasal spray epinephrine drug, providing needle-free alternative to EpiPens and similar medicinesOmalizumab for the treatment of multiple food allergies (References: NEJM article)Palforzia and oral immunotherapy for peanut allergies (References: https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300145)

Episode metadata supplied by the publisher feed · Published Jun 20, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

5-Minute Check In: New Developments in Allergy Treatments

0:00 6:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn?

This episode is 6 minutes long.

When was this 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn episode published?

This episode was published on June 20, 2025.

Can I download this 5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!